Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:209-218

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumagai, K.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumagai, K.
Right arrow Articles by Saruta, T.

(Hypertension. 1996;27:209-218.)
© 1996 American Heart Association, Inc.


Articles

Comparison of Early and Late Start of Antihypertensive Agents and Baroreceptor Reflexes

Kazuhiro Kumagai; Hiromichi Suzuki; Masashi Ichikawa; Masahito Jimbo; Masahiko Nishizawa; Munekazu Ryuzaki; Takao Saruta

From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

Correspondence to Takao Saruta, MD, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan.

Abstract Along with arterial blood pressure reduction, maintenance of the integrity of baroreceptor reflex function contributes to preserving end-organ function in the treatment of hypertensive patients. The purpose of this study was to investigate the effects of antihypertensive agents (trichlormethiazide, atenolol, nicardipine, and enalapril) on baroreceptor reflex function by comparing early and late starts of treatment. We administered each agent to spontaneously hypertensive rats (SHR) as early-start groups from 10 to 36 weeks of age and as late-start groups from 28 to 36 weeks of age. We evaluated the gain of the reflex control of renal sympathetic nerve activity and heart rate using ramp infusions of phenylephrine and nitroglycerin in untreated SHR at 10, 28, or 36 weeks of age and in treated SHR at 36 weeks of age. In 28- and 36-week-old untreated SHR, the renal sympathetic nerve activity gain was not altered and the heart rate gain was decreased (from -2.3±0.3 to -1.3±0.3 and -1.2±0.3 beats per minute [bpm]/mm Hg, P<.05, respectively) compared with 10-week-old SHR. Early and late start of therapy produced arterial pressure reductions (-18±4 and -12±5 mm Hg, P<.05, respectively). In the early-start groups, the renal sympathetic nerve activity gain was improved markedly in nicardipine- and enalapril-treated SHR (-4.2±0.2% and -4.9±0.2% of control/mm Hg, P<.01, respectively), and the heart rate gain was improved markedly in atenolol- and enalapril-treated SHR (-4.1±0.2 and -4.4±0.2 bpm/mm Hg, P<.01, respectively). In the late-start groups, the renal sympathetic nerve activity gain was improved moderately in nicardipine- and enalapril-treated SHR (-3.8±0.2% and -2.9±0.2% of control/mm Hg, P<.05, respectively). The heart rate gain was improved slightly only in nicardipine-treated SHR (-1.9±0.2 bpm/mm Hg, P<.05). These results demonstrate that an early start of antihypertensive treatment improves baroreceptor reflex function markedly compared with a late start of treatment. This supports the hypothesis that a possible critical phase sensitive to intervention with antihypertensive treatment exists during the development of hypertension and indicates that the early start of antihypertensive treatment would be required in clinical practice.


Key Words: diuretics • receptors, adrenergic, beta • calcium channel blockers • angiotensin-converting enzyme inhibitors • baroreflex • rats, inbred SHR




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
M. Petersson, P. Friberg, G. Lambert, and B. Rundqvist
Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure
Eur J Heart Fail, October 1, 2005; 7(6): 1003 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Bunag, J. Mellick, and B. Allen
Abated cardiovascular responses to chronic oral lisinopril treatment in conscious elderly rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1408 - R1415.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Nishizawa, H. Kumagai, M. Ichikawa, N. Oshima, H. Suzuki, and T. Saruta
Improvement in Baroreflex Function by an Oral Angiotensin Receptor Antagonist in Rats With Myocardial Infarction
Hypertension, January 1, 1997; 29(1): 458 - 463.
[Abstract] [Full Text] [PDF]